OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Activation of lateral hypothalamic group III metabotropic glutamate receptors suppresses cocaine-seeking following abstinence and normalizes drug-associated increases in excitatory drive to orexin/hypocretin cells
Jiann Wei Yeoh, Morgan H. James, Cameron D. Adams, et al.
Neuropharmacology (2018) Vol. 154, pp. 22-33
Open Access | Times Cited: 18
Jiann Wei Yeoh, Morgan H. James, Cameron D. Adams, et al.
Neuropharmacology (2018) Vol. 154, pp. 22-33
Open Access | Times Cited: 18
Showing 18 citing articles:
Increased Number and Activity of a Lateral Subpopulation of Hypothalamic Orexin/Hypocretin Neurons Underlies the Expression of an Addicted State in Rats
Morgan H. James, Colin M. Stopper, Benjamin Zimmer, et al.
Biological Psychiatry (2018) Vol. 85, Iss. 11, pp. 925-935
Open Access | Times Cited: 178
Morgan H. James, Colin M. Stopper, Benjamin Zimmer, et al.
Biological Psychiatry (2018) Vol. 85, Iss. 11, pp. 925-935
Open Access | Times Cited: 178
Amygdala NPY Circuits Promote the Development of Accelerated Obesity under Chronic Stress Conditions
Chi Kin Ip, Lei Zhang, Aitak Farzi, et al.
Cell Metabolism (2019) Vol. 30, Iss. 1, pp. 111-128.e6
Open Access | Times Cited: 103
Chi Kin Ip, Lei Zhang, Aitak Farzi, et al.
Cell Metabolism (2019) Vol. 30, Iss. 1, pp. 111-128.e6
Open Access | Times Cited: 103
Recent perspectives on orexin/hypocretin promotion of addiction-related behaviors
F. Woodward Hopf
Neuropharmacology (2020) Vol. 168, pp. 108013-108013
Open Access | Times Cited: 50
F. Woodward Hopf
Neuropharmacology (2020) Vol. 168, pp. 108013-108013
Open Access | Times Cited: 50
Sleep dysregulation in binge eating disorder and “food addiction”: the orexin (hypocretin) system as a potential neurobiological link
Jacqueline B. Mehr, Deborah Mitchison, Hannah E. Bowrey, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 12, pp. 2051-2061
Open Access | Times Cited: 46
Jacqueline B. Mehr, Deborah Mitchison, Hannah E. Bowrey, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 12, pp. 2051-2061
Open Access | Times Cited: 46
Orexin Reserve: A Mechanistic Framework for the Role of Orexins (Hypocretins) in Addiction
Morgan H. James, Gary Aston‐Jones
Biological Psychiatry (2022) Vol. 92, Iss. 11, pp. 836-844
Open Access | Times Cited: 33
Morgan H. James, Gary Aston‐Jones
Biological Psychiatry (2022) Vol. 92, Iss. 11, pp. 836-844
Open Access | Times Cited: 33
Sleep loss and addiction
Luis Angel López-Muciño, Fabio García‐García, Jonathan Cueto‐Escobedo, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 141, pp. 104832-104832
Closed Access | Times Cited: 26
Luis Angel López-Muciño, Fabio García‐García, Jonathan Cueto‐Escobedo, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 141, pp. 104832-104832
Closed Access | Times Cited: 26
Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil
Aida Mohammadkhani, Morgan H. James, Caroline B. Pantazis, et al.
Brain Research (2019) Vol. 1731, pp. 146461-146461
Open Access | Times Cited: 41
Aida Mohammadkhani, Morgan H. James, Caroline B. Pantazis, et al.
Brain Research (2019) Vol. 1731, pp. 146461-146461
Open Access | Times Cited: 41
The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse
Morgan H. James, Jennifer E. Fragale, Shayna L. O’Connor, et al.
Neuropharmacology (2020) Vol. 183, pp. 108359-108359
Open Access | Times Cited: 29
Morgan H. James, Jennifer E. Fragale, Shayna L. O’Connor, et al.
Neuropharmacology (2020) Vol. 183, pp. 108359-108359
Open Access | Times Cited: 29
Electroacupuncture Enhances Neuroplasticity by Regulating the Orexin A-Mediated cAMP/PKA/CREB Signaling Pathway in Senescence-Accelerated Mouse Prone 8 (SAMP8) Mice
Zhitao Hou, Xinyu Yang, Yang Li, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 16
Zhitao Hou, Xinyu Yang, Yang Li, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 16
Contribution of hypothalamic orexin (hypocretin) circuits to pathologies of motivation
Aida Mohammadkhani, Caitlin Mitchell, Morgan H. James, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 3
Aida Mohammadkhani, Caitlin Mitchell, Morgan H. James, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 3
The orexin-1 receptor antagonist SB-334867 reduces motivation, but not inhibitory control, in a rat stop signal task
Joost Wiskerke, Morgan H. James, Gary Aston‐Jones
Brain Research (2019) Vol. 1731, pp. 146222-146222
Open Access | Times Cited: 26
Joost Wiskerke, Morgan H. James, Gary Aston‐Jones
Brain Research (2019) Vol. 1731, pp. 146222-146222
Open Access | Times Cited: 26
Cocaine-Seeking Behavior Induced by Orexin A Administration in the Posterior Paraventricular Nucleus of the Thalamus Is Not Long-Lasting: Neuroadaptation of the Orexin System During Cocaine Abstinence
Alessandra Matzeu, Rémi Martin‐Fardon
Frontiers in Behavioral Neuroscience (2021) Vol. 15
Open Access | Times Cited: 15
Alessandra Matzeu, Rémi Martin‐Fardon
Frontiers in Behavioral Neuroscience (2021) Vol. 15
Open Access | Times Cited: 15
Circadian Influences on the Habenula and Their Potential Contribution to Neuropsychiatric Disorders
Callum J. Young, D. Lyons, Hugh D. Piggins
Frontiers in Behavioral Neuroscience (2022) Vol. 15
Open Access | Times Cited: 9
Callum J. Young, D. Lyons, Hugh D. Piggins
Frontiers in Behavioral Neuroscience (2022) Vol. 15
Open Access | Times Cited: 9
Group III metabotropic glutamate receptors regulate hypothalamic presympathetic neurons through opposing presynaptic and postsynaptic actions in hypertension
Jing‐Jing Zhou, Judith Pachuau, De‐Pei Li, et al.
Neuropharmacology (2020) Vol. 174, pp. 108159-108159
Open Access | Times Cited: 10
Jing‐Jing Zhou, Judith Pachuau, De‐Pei Li, et al.
Neuropharmacology (2020) Vol. 174, pp. 108159-108159
Open Access | Times Cited: 10
Emerging Nano-based Therapeutic Approaches for Neurogenetic Disorders
Pemula Gowtham, Koyeli Girigoswami, Pragya Pallavi, et al.
Biomedical Research and Therapy (2023) Vol. 10, Iss. 2, pp. 5558-5574
Open Access | Times Cited: 2
Pemula Gowtham, Koyeli Girigoswami, Pragya Pallavi, et al.
Biomedical Research and Therapy (2023) Vol. 10, Iss. 2, pp. 5558-5574
Open Access | Times Cited: 2
Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil
Aida Mohammadkhani, Morgan H. James, Gary Aston‐Jones
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 5
Aida Mohammadkhani, Morgan H. James, Gary Aston‐Jones
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 5
The orexin-1 receptor antagonist SB-334867 reduces motivation, but not inhibitory control, in a rat stop signal task
Joost Wiskerke, Morgan H. James, Gary Aston‐Jones
bioRxiv (Cold Spring Harbor Laboratory) (2018)
Open Access | Times Cited: 4
Joost Wiskerke, Morgan H. James, Gary Aston‐Jones
bioRxiv (Cold Spring Harbor Laboratory) (2018)
Open Access | Times Cited: 4
Hypothalamic control of homeostasis
Stephanie L. Borgland, Christopher V. Dayas
Neuropharmacology (2019) Vol. 154, pp. 1-3
Closed Access | Times Cited: 2
Stephanie L. Borgland, Christopher V. Dayas
Neuropharmacology (2019) Vol. 154, pp. 1-3
Closed Access | Times Cited: 2
